Comparing the current results to its competitors, Avanos Medical Inc reported Revenue increase in the 1 quarter 2026 by 9.23 % year on year. The sales growth was above Avanos Medical Inc 's competitors' average revenue growth of 6.73 %, achieved in the same quarter.
Avanos Medical Inc 's Comment on Competition and Industry Peers
The company competes in U.S. and international markets across various treatment methods and alternative clinical practices for pain management, recovery, and enteral feeding. In Specialty Nutrition Systems, major competitors include Boston Scientific Corporation, Cook Medical, Applied Medical Technology, Inc., and Cardinal Health. In Pain Management and Recovery, key competitors are Boston Scientific Corporation, Pacira Pharmaceuticals, Inc., Stryker Corporation, Medtronic plc, Pajunk Medical Systems, Stratus Medical, and Nice Recovery Systems. In developing and emerging markets, competition primarily arises from alternative clinical practices and differing standards of care. The company maintains its market positions by introducing new products and completing acquisitions, such as the Nexus Acquisition, which expanded its portfolio into the vascular access market.
With revenue growth of 9.23 % within Overall company, Avanos Medical Inc achieved improvement in market share, within Overall company to approximately 1.51 %. << More on AVNS Market Share.
*Market share is calculated based on total revenue.
Henry Schein Inc operates as a global distributor of healthcare products, services, and technology solutions, primarily targeting dental and medical professionals. Their business model emphasizes a vast network of sales consultants and a diverse product range from various manufacturers, aiming to deliver high-quality products, innovative solutions, and exceptional customer service to enhance patient care and improve practice efficiency.
Retractable Technologies Inc. is a medical device manufacturing company that specializes in the production of retractable needle systems. Their business model revolves around developing and distributing innovative safety medical products that protect healthcare workers from accidental needlestick injuries. By offering a range of retractable needle solutions, they aim to improve workplace safety and reduce the potential transmission of bloodborne diseases.
Nuwellis Inc.'s business model revolves around developing and commercializing innovative therapeutic solutions, predominantly focusing on fluid management to improve outcomes for patients with critical illnesses. They aim to provide advanced medical devices and solutions to healthcare professionals, addressing the pressing need for better fluid management in critical care settings.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Sources:
Avanos Medical Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Avanos Medical Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
